Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Clinical Trial of an Algorithm Driven Sepsis Prediction Biomarker

NCT03015454 is registered in ClinicalTrials.gov with Dascena as lead sponsor.

NCT NCT03015454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03015454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Clinical Trial of an Algorithm Driven Sepsis Prediction Biomarker
Lead sponsor
Dascena
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2016
Completion date
Not reported
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock, severe sepsis